Combined blockade of VEGFR-3 and Itga-9 inhibits corneal lymphangiogenesis and valvulogenesis in vivo and promotes high-risk transplant survival.

چکیده

Corneal transplantation is the last hope for vision restoration for corneal blindness. The rejection rate of high-risk grafts can be 50-90%, irrespective of current treatment modalities. As VEGFR-3 (vascular endothelial growth factor receptor-3) is a central regulator of lymphatic vessel formation…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• قرنیه